All News
Filter News
Found 6,663 articles
-
Gilead Sciences, Inc. to Present at the Goldman, Sachs & Co. 34th Annual Healthcare Conference on Tuesday, June 11
6/11/2013
-
Gilead Sciences, Inc. Announces FDA Priority Review Designation for Sofosbuvir for the Treatment of Hepatitis C
6/10/2013
-
Immune Response BioPharma Phase II IR103 Study Results IR103 REMUNEX Provides Maximum Effect
6/10/2013
-
Royalty Pharma Acceptances Announcement
6/10/2013
-
Peter J. Carbonaro Joins Atossa Genetics, Inc. as Senior Vice President of Operations
6/5/2013
-
Dohmen’s BioSoteria, Inc. Calls for Abstracts for Its Seventh Annual Pacific Drug Safety Summit (PDSS)
5/31/2013
-
Advanced Biological Laboratories SA (ABL) Receives CE Mark for It's TherapyEdge®
5/29/2013
-
Gilead Sciences, Inc. to Present at the Deutsche Bank 38th Annual Health Care Conference on Wednesday, May 29
5/29/2013
-
European Commission (EC) Approves Gilead Sciences, Inc.'s Stribild as Single Tablet Regimen for HIV-1 Treatment
5/28/2013
-
Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Corporation PLC Pursuant to Irish and United States Regulatory Requirements
5/28/2013
-
Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
5/24/2013
-
European Medicines Agency Validates Gilead Sciences, Inc.'s Marketing Application for Sofosbuvir for the Treatment of Hepatitis C
5/22/2013
-
Primary Efficacy and Safety Findings from Phase 3 Study of Janssen Research & Development's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
5/21/2013
-
Royalty Pharma Increases Offer for Elan Corporation PLC to $12.50 Per Share in All Cash
5/21/2013
-
Effector Therapeutics Raises $45 Million Series A to Fight Cancer Tumors
5/20/2013
-
Gilead Sciences, Inc. to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20
5/20/2013
-
AnaptysBio, Inc. Awarded U.S. Government Contract to Develop Anti-Ricin Antibodies
5/17/2013
-
Experimental Gilead Sciences, Inc. Drug Effective in Early-Stage Leukemia Trial
5/16/2013
-
Cancer Genetics, Inc. Announces First Quarter 2013 Financial Results and Significant Business and Portfolio Progress
5/16/2013
-
Gilead Sciences, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15
5/15/2013